Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/SYNAPTOGENIX-INC-120797989/news/Synaptogenix-gibt-erste-Ergebnisse-der-von-den-NIH-geforderten-klinischen-Phase-2-Studie-mit-Bryost-42569786/?utm_source=whatsapp&utm_medium=social&utm_campaign=share